Patents Examined by Manjunath Rao
-
Patent number: 9816127Abstract: The present invention provides an assay for detection of oxidized glutathione (GSSG).Type: GrantFiled: August 31, 2011Date of Patent: November 14, 2017Assignee: PROMEGA CORPORATIONInventors: Fen Huang, Dieter Klaubert, John Shultz, Wenhui Zhou
-
Patent number: 9731052Abstract: The invention provides a method for the controlled assembly of layered silk fibroin coatings using aqueous silk fibroin material. The methods described herein can be used to coat substrates of any material, shape, or size. Importantly, the described methods enable control of the biomaterial surface chemistry, thickness, morphology and structure using layered thin film coatings, or bulk coatings. Furthermore, the methods can be performed in all water and do not require intensive chemical processing enabling controlled entrapment of labile molecules such as, drugs, cytokines, and even cells or viruses to generate functional coatings that can be used in a variety of applications.Type: GrantFiled: May 6, 2015Date of Patent: August 15, 2017Assignee: Trustees of Tufts CollegeInventors: David L. Kaplan, Xianyan Wang
-
Patent number: 9688970Abstract: A new, reliable, easily scalable and reproducible method for the production of recombinant butyrylcholinesterase (rBuChE) is provided. Through the utilization of a plant transfection procedure, various plant strains have been shown to generate effective and scalable amounts of rBuChE under acceptable manufacturing processes to permit reliable levels of such enzymes for desired nerve agent protection requirements (including tetrameric products). As well, such methods in engineered plant lines have shown suitable production of these enzymes in tetramer form with glycan formation and sialyalation (for terminal groups) to allow for optimal potency against organophosphorus agent exposure as well as proper immunogenic response within the plant sources. The overall production method, including the transfection and production within mammalian cells, as well as the process steps involved for such a reliable sourcing platform from plants is thus encompassed within the invention.Type: GrantFiled: July 31, 2014Date of Patent: June 27, 2017Assignee: Kentucky BioProcessing, Inc.Inventors: Greg Pogue, Ernie Hiatt, Romy Kandzia, Stefan Werner, Frank Thieme, Tsafrir Mor, Steven Hume
-
Patent number: 9624281Abstract: In one aspect the present invention is directed to mutant NGAL proteins that have the ability to bind to siderophores, such as enterochelin, and to chelate and transport iron, and that are excreted in the urine. Such NGAL mutants, and complexes thereof with siderophores, can be used to clear excess iron from the body, for example in the treatment of iron overload. The NGAL mutants of the invention also have antibacterial activity and can be used in the treatment of bacterial infections, such as those of the urinary tract.Type: GrantFiled: May 21, 2015Date of Patent: April 18, 2017Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKInventors: Jonathan Barasch, Andong Qiu
-
Patent number: 9458222Abstract: Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a high specific activity and ADAMTS13 with a high specific activity. The cell culture conditions of the present invention can include, for example, a cell culture medium with an increased copper concentration and/or cell culture supernatant with a low ammonium (NH4+) concentration. The present invention also provides methods for cultivating cells in the cell culture conditions to express high molecular weight vWF and rA13 having high specific activities.Type: GrantFiled: July 8, 2011Date of Patent: October 4, 2016Assignees: Baxalta Incorporated, Baxalta GmbHInventors: Leopold Grillberger, Manfred Reiter, Daniel Fleischanderl, Gregor Bramberger
-
Patent number: 9447401Abstract: Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.Type: GrantFiled: December 28, 2012Date of Patent: September 20, 2016Assignee: Halozyme, Inc.Inventors: Ge Wei, H. Michael Shepard, Qiping Zhao, Robert James Connor
-
Patent number: 9447385Abstract: From a bacterial strain isolated from an environmental sample, after enrichment in medium containing 1-butanol as the carbon source, a new enzyme with butanol dehydrogenase activity was identified. The enzyme can convert butyraldehyde to 1-butanol, isobutyraldehyde to isobutanol, as well as 2-butanone to 2-butanol and thus is useful for biosynthesis of butanol in recombinant microbial hosts producing these substrates. The encoding gene, named sadB, was isolated from the strain identified as an isolate of Achromobacter xylosoxidans.Type: GrantFiled: February 13, 2014Date of Patent: September 20, 2016Assignee: Butamax Advanced Biofuels LLCInventors: Michael G. Bramucci, Andrew C. Eliot, Lori Ann Maggio-Hall, Charles E. Nakamura
-
Patent number: 9440006Abstract: A method for forming a porous tissue material.Type: GrantFiled: May 6, 2014Date of Patent: September 13, 2016Assignee: FUJIFILM CorporationInventor: Huibert Van Boxtel
-
Patent number: 9434915Abstract: The present invention provides a Bacillus sp. subtilisin variant. In addition, the present invention provides automatic dishwashing compositions comprising this serine protease variant.Type: GrantFiled: February 5, 2015Date of Patent: September 6, 2016Assignee: Danisco US Inc.Inventors: David A. Estell, Frits Goedegebuur, Ayrookaran J. Poulose
-
Patent number: 9434919Abstract: The present invention provides fungal proteases and improved fungal strains that are deficient in protease production.Type: GrantFiled: November 24, 2015Date of Patent: September 6, 2016Assignee: Codexis, Inc.Inventors: Lorand Szabo, Zsolt Molnar, Attila Laszlo Nemeth
-
Patent number: 9422541Abstract: An apparatus for the extracorporeal treatment of blood comprising an extracorporeal blood circuit (2), a pump (6) configured to provide fluid displacement within the extracorporeal blood circuit, and a reaction chamber (8) connected to the extracorporeal blood circuit and configured to receive blood or plasma from the circuit and treat the blood or plasma. The reaction chamber comprises an protease enzyme immobilized to a support, in which the protease enzyme is specific for, and capable of irreversibly cleaving, a human C5a present in the blood or plasma, wherein the abundance of the human C5a in the treated blood or plasma is less than that in the untreated blood or plasma. The apparatus finds utility in the extracorporeal treatment of blood from patients with inflammatory conditions, especially auto-immune disease and sepsis.Type: GrantFiled: June 25, 2014Date of Patent: August 23, 2016Assignee: University of LimerickInventors: Jakki Cooney, Todd Fumio Kagawa, Edmond Magner
-
Patent number: 9416355Abstract: The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants and to nucleic acid constructs, vectors, and host cells comprising the polynucleotides, and methods of using the variant enzymes.Type: GrantFiled: January 4, 2011Date of Patent: August 16, 2016Assignees: NOVOZYMES NORTH AMERICA, INC., NOVOZYMES A/SInventors: Carsten Andersen, Randall Deinhammer, Thomas Agersten Poulsen, Miguel Duarte Toscano, Peter Kamp Hansen, Henrik Friis-Madsen, Anders Viksoe-Nielsen, Signe Eskildsen Larsen, Lars L. H. Christensen
-
Patent number: 9410135Abstract: The present disclosure relates to mutant thermostable glycosyl hydrolases family 7 enzymes, including mutant Trichoderma reesei endoglucanase I. In particular, the present disclosure relates to mutant thermostable enzymes, compositions containing the enzymes, and methods of use thereof.Type: GrantFiled: August 11, 2011Date of Patent: August 9, 2016Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Harshal Akshay Chokhawala, Tae-Wan Kim, Harvey W. Blanch, Douglas S. Clark
-
Patent number: 9410166Abstract: The invention relates to suitable candidate alcohol dehydrogenase (ADH) enzymes for production of lower alkyl alcohols including isobutanol. The invention also relates to recombinant host cells that comprise such ADH enzymes and methods for producing lower alkyl alcohols in the same.Type: GrantFiled: May 20, 2014Date of Patent: August 9, 2016Assignee: Butamax Advanced Biofuels LLCInventors: Sriram Satagopan, Daniel P. O'Keefe, Janardhan Gude
-
Patent number: 9388403Abstract: Improving wild nitrile hydratase enables the provision of a protein which has nitrile hydratase activity and which has further improved heat resistance, amide compound resistance and high temperature accumulation properties. Use protein (A) or (B), (A) being a protein characterized by having nitrile hydratase activity and by including an amino acid sequence in which a specific amino acid residue in an amino acid sequence in wild nitrile hydratase has been substituted by another amino acid residue, and (B) being a protein characterized by having nitrile hydratase activity and by including an amino acid sequence in which one or several amino acid residues in the amino acid sequence of protein (A), other than the abovementioned specific amino acid residue, is deleted, substituted and/or added.Type: GrantFiled: May 30, 2012Date of Patent: July 12, 2016Assignee: Mitsubishi Rayon Co., Ltd.Inventors: Fumiaki Watanabe, Takanori Ambo, Ai Hara
-
Patent number: 9382422Abstract: The invention provides tissue repair compositions and methods of making the tissue repair compositions. Also featured are methods of treatment using the tissue repair compositions and articles of manufacture that include the tissue repair compositions.Type: GrantFiled: July 9, 2008Date of Patent: July 5, 2016Assignee: LifeCell CorporationInventors: Rick T. Owens, Wendell Sun
-
Patent number: 9382528Abstract: Improving wild nitrile hydratase enables the provision of a protein which has nitrile hydratase activity and which has further improved heat resistance, amide compound resistance and high temperature accumulation properties. Use protein (A) or (B), (A) being a protein characterised by having nitrile hydratase activity and by including an amino acid sequence in which a specific amino acid residue in an amino acid sequence in wild nitrile hydratase has been substituted by another amino acid residue, and (B) being a protein characterised by having nitrile hydratase activity and by including an amino acid sequence in which one or several amino acid residues in the amino acid sequence of protein (A), other than the abovementioned specific amino acid residue, is deleted, substituted and/or added.Type: GrantFiled: April 17, 2015Date of Patent: July 5, 2016Assignee: Mitsubishi Rayon Co., Ltd.Inventors: Fumiaki Watanabe, Takanori Ambo, Ai Hara
-
Patent number: 9381282Abstract: The invention provides methods, compositions, and devices for promoting adhesion or migration of endothelial cell.Type: GrantFiled: July 30, 2014Date of Patent: July 5, 2016Assignee: University of Utah Research FoundationInventors: Dean Y. Li, Brent D. Wilson, Lise Sorensen Brunhart
-
Patent number: 9359584Abstract: Provided in part herein are compositions that include isolated microbial enzymes, such as amylases, lipases, and proteases that are useful as detergent additives. Also provided are methods of isolating amylases, lipases, and proteases from microbes, as well as methods of using these enzymes as detergent additives, and for stain removal.Type: GrantFiled: July 24, 2010Date of Patent: June 7, 2016Assignee: WEST BENGAL UNIVERSITY OF TECHNOLOGYInventor: Shaon Ray Chaudhuri
-
Patent number: 9353358Abstract: The subject of the invention is the ribonuclease which cleaves RNA strand in DNA-RNA hybrids, wherein ribonuclease comprises fusion protein comprising catalytic domain of RNase HI (RNase HI) or derivative thereof with a zinc finger DNA-RNA hybrid binding domain, and wherein the zinc finger binding domain has the ability to bind to specific sequences in the DNA-RNA hybrid. The invention also relates to new methods for determination of the sequence preference of DNA-RNA hybrid binding protein(s) or its domain(s) and allows determining the sequence recognized by sequence specific binding protein in the DNA-RNA hybrid.Type: GrantFiled: December 3, 2013Date of Patent: May 31, 2016Assignee: MIEDZYNARODOWY INSTYTUT BIOLOGII MOLEKULARNEJ I KOMORKOWEJInventors: Janusz Marek Bujnicki, Agata Agnieszka Sulej, Krzysztof Jerzy Skowronek, Marcin Nowotny